⌘K

Login Start Free

Home/Filings/4/0001209191-03-028530

4//SEC Filing

GIOTTA GREGORY J 4

Accession 0001209191-03-028530

CIK 0001012140other

View on SEC.gov Company Profile

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 8:10 PM ET

Size

19.2 KB

Accession

0001209191-03-028530

Insider Transaction Report

Form 4

Period: 2003-11-03

ONYX PHARMACEUTICALS INCONXX

GIOTTA GREGORY J

VP & Chief Legal Counsel

Transactions

Sale
Common Stock
2003-11-04$24.44/sh−23,588$576,491→ 0 total
Sale
Common Stock
2003-11-03$24.11/sh−500$12,055→ 0 total
Exercise/Conversion
Common Stock
2003-11-04$5.00/sh+5,000$25,000→ 0 total
Sale
Common Stock
2003-11-04$24.45/sh−500$12,225→ 0 total
Exercise/Conversion
Common Stock
2003-11-03$4.00/sh+7,813$31,252→ 0 total
Exercise/Conversion
Common Stock
2003-11-04$4.87/sh+9,583$46,669→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2003-11-04−9,505→ 10,938 total
Exercise: $10.52From: 2002-01-27Exp: 2011-07-27→ Common Stock (9,505 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2003-11-03−7,813→ 17,187 total
Exercise: $4.00From: 2003-01-22Exp: 2012-07-22→ Common Stock (7,813 underlying)
Exercise/Conversion
Common Stock
2003-11-04$10.52/sh+9,505$99,993→ 0 total
Sale
Common Stock
2003-11-03$24.00/sh−16,313$391,512→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2003-11-04−5,000→ 25,000 total
Exercise: $5.00From: 2003-08-12Exp: 2013-02-12→ Common Stock (5,000 underlying)
Sale
Common Stock
2003-11-03$24.03/sh−11,000$264,330→ 0 total
Exercise/Conversion
Common Stock
2003-11-03$6.13/sh+20,000$122,500→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2003-11-04−9,583→ 10,417 total
Exercise: $4.87From: 2002-05-06Exp: 2011-11-06→ Common Stock (9,583 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2003-11-03−20,000→ 0 total
Exercise: $6.13From: 2003-03-19Exp: 2009-03-19→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The option becomes exercisable as to 12.5% of the grant 6 months after the date of grant and monthly thereafter for a total of 4 years.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ONYX PHARMACEUTICALS INC

CIK 0001012140

Entity typeother

Related Parties

1

filerCIK 0001235860

Filing Metadata

Form type: 4
Filed: Nov 3, 7:00 PM ET
Accepted: Nov 4, 8:10 PM ET
Size: 19.2 KB

View on SEC.gov